Skip to content

Similar metrics at other companies

Crocs logo
CROXHEYDUDE Brand — D&A
$5.98M+7.5%
MDU Resources Group logo
MDUOther — D&A
$0
Priority Technology Holdings logo
PRTHPayables — D&A
$1.29M+2.1%
Seaboard logo
SEBCorporate And Other — D&A
$3M0.0%
Laureate Education, Inc. logo
LAURD&A
$22.58M+40.5%
VHI
VHIChemicals — D&A
$16M+11.1%

Other financials

Income statement

See full
Revenue$250.2M+0.3%
Gross profit$190.8M-3.2%
Operating income$13.9M-11.5%
Net income$7.5M-20.1%
EPS (diluted)$0.41-16.3%

Balance sheet

See full
Cash & equivalents$165.7M-9.2%
Total debt$18.0M+10.8%
Total equity$543.6M+2.6%
Total assets$739.0M-1.0%

Cash flow

See full
Operating cash flow$9.8M-37.0%
CapEx$2.6M-5.6%
Free cash flow$7.1M-43.9%

Valuation

See full
Market cap$363.35M-36.1%
P/E18.1×+7.8×
P/S0.4×-0.3×

Profitability

See full
Gross margin77.6%-3.0pp
Operating margin3.8%-2.7pp
Net margin1.9%-4.4pp
FCF margin5.7%-1.1pp

Returns & leverage

See full
Return on equity3.2%-7.6pp
Debt / equity0.0×
Current ratio2.5×+0.5×

Where this comes from

Reported directly by USANA Health Sciences in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's hiya — d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is USANA Health Sciences's hiya — D&A?
USANA Health Sciences (USNA) reported hiya — D&A of $4.47M in Q1 2026.
How has USANA Health Sciences's hiya — D&A changed year-over-year?
USANA Health Sciences's hiya — D&A decreased by 0.3% year-over-year, from $4.48M to $4.47M.
What does hiya — D&A mean?
Combines the periodic allocation of costs for both tangible fixed assets and intangible assets specific to the Hiya segment. This metric accounts for the wear and tear of physical equipment and the expiration of intangible rights used in segment operations. It is a key component in reconciling net income to cash flow from operations for the segment.